Allergan

Allergan promotes a diverse portfolio of top brands and pharmacological treatments in numerous fields. They include therapeutic areas of the central nerves, vision care, med aesthetics and dermatitis, endoscopy, maternal issues, nephrology, and pro clinical categories. The firm has commercial production in almost 100 countries. It is committed to collaborating with doctors, health professionals, and patients to develop new and meaningful therapies that allow people all over the globe to live longer and happier.

Allergan is an entrepreneurial leader in Open Science. The research and innovation paradigm outlines their approach to finding and producing game-changing innovative products. As a result of these strategies, Allergan has developed one of the most comprehensive development pathways in the pharmaceutical business.

To this day, they continue to construct a long-term sustainable firm that generates profitability for shareholders and the economic stability to invest. They also desire to extend their reach to multiple regions, serving the best interests of people and families throughout the globe.

Founded: 1983

Headquarters (Canada branch): Markham, ON

Revenue: $16.09B

Website: https://www.allergan.com/